Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report) rose 1.2% during trading on Friday . The stock traded as high as $27.38 and last traded at $27.38. Approximately 482 shares traded hands during trading, a decline of 89% from the average daily volume of 4,288 shares. The stock had previously closed at $27.04.
Virtus LifeSci Biotech Clinical Trials ETF Stock Performance
The firm’s 50-day simple moving average is $28.43 and its 200 day simple moving average is $23.46.
Virtus LifeSci Biotech Clinical Trials ETF Company Profile
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
See Also
About us
NewsGala, a modern financial media outlet by Zeni Capital Corp. With 35 years of international finance expertise NewsGala strips away the distractions to provide timely and relevant financial news.
Our mission is to position our readers to have the best information to make profitable financial decisions and set realistic goals.
Company
Subscribe
© 2021 Newsgala.com. All Rights Reserved.